Navigation Links
Advanced Life Sciences Announces Restanza(TM) Shows Efficacy Against Malaria
Date:5/26/2010

portfolio of indications that we can develop and commercialize either on our own or in partnership with pharmaceutical companies with established anti-infective franchises."

About Malaria

Malaria is a parasitic disease that is characterized by high fevers, shaking chills, flu-like symptoms, and anemia, and requires hospitalization. Malaria is typically caused by a parasite that is transmitted from one human to another by the bite of infected mosquitoes. Malaria can also be transmitted from a mother to her unborn baby and by blood transfusions. In humans, the parasites (sporozoites) travel to the liver where they mature and release another form, the merosoites, which enter the bloodstream and infect red blood cells. The parasites multiply inside the red blood cells, which then rupture within 48 to 72 hours, infecting more red blood cells. The first symptoms usually occur 10 days to four weeks after infection, though they can appear as early as eight days or as long as a year after infection.

Malaria is a serious health problem in much of the tropics and subtropics and represents a major disease hazard for travelers to these regions and other warm climates. The widespread prevalence of malaria in Africa poses a severe social and economic threat. The Centers for Disease Control and Prevention (CDC) estimates that there are 300-500 million cases of malaria each year, resulting in more than one million deaths, many among very young children. Conventional treatment includes chloroquine, quinidine or quinine. In some areas of the world, the parasites have developed resistance to antibiotic treatments (doxycycline, tetracycline or clindamycin, atovaquone plus proguanil, mefloquine or artesunate, or the combination of pyrimethamine and sulfaxcozine). This has led to difficulty in controlling both the rate of infection and spread of this dis
'/>"/>

SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Tumor-Targeted Rexin-G Prolongs Survival in Gemcitabine-Resistant Metastatic Pancreas Cancer in Advanced Phase I and II Studies (ASCO 2010)
2. Elekta / Mitsubishi Electric Collaboration Helps Japans Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer
3. Merrimack Pharmaceuticals Initiates Enrollment in Phase 1/2 Combination Study of MM-111 and Herceptin in Patients with Advanced Her2 Positive Breast Cancer
4. Advanced BioFuels Association Applauds U.S. Sen. Bill Nelsons Leadership as Biofuels Tax Incentives Bill Is Introduced
5. Advanced Life Sciences to Host 2010 First Quarter Financial Results Conference Call and Webcast
6. Upgrade to Advanced Photon Source Announced by DOE
7. Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications
8. Atherotechs Advanced Lipid Profile Featured in Lipoprotein and Epidemiology Research at ACC 2010
9. Citius Tech Launches BI-Clinical MUSE for Advanced "Meaningful Use" Reporting and Data Submission, and Performance Management for Healthcare ISVs
10. Advanced Instruments Signs License and Sensor Development Agreement With Cantimer, Inc.
11. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Can economic incentives such as gift cards, ... the public to increase their donations of blood? , ... Business School Assistant Professor Mario Macis says the ... body of recent research that supports their argument, the ... of Science that the World Health Organization and national ...
(Date:5/23/2013)... 23, 2013  Rahal Letterman Lanigan Racing (RLL) and ... stem cell banking and therapeutics, announced today that StemCyte ... Acorn Stairlifts Indy car driven by James ... the IZOD IndyCar 2013 season.   StemCyte, ... support awareness of umbilical cord blood banking and its ...
(Date:5/23/2013)...  Saddleback Memorial Medical Center in Laguna ... on the West Coast to perform a hysterectomy using ... women with a state-of-the-art, minimally invasive approach to gynecological ... , M.D., a highly regarded Orange County ... minimally invasive surgery at Saddleback Memorial, led the surgical ...
(Date:5/23/2013)... May 23, 2013 Z Trim Holdings, Inc. ... to a variety of industries, announced that Chef ... discussion at this year,s National Restaurant Association ("NRA") NRA ... behalf of the Research Chefs Association.  Chef Ryan spoke ... Good, the Bad and the Ugly," joining four other ...
Breaking Biology Technology:Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3
... Pipeline Efforts at 27th Annual J.P. Morgan Healthcare Conference ... (Nasdaq: GHDX ) announced today that it ... 18-gene Oncotype DX(R) colon cancer assay. Utilizing more ... the validation study will use prospectively defined endpoints to ...
... Jan. 12 WaferGen Biosystems,Inc. (OTC Bulletin ... gene,expression, genotyping, cell biology and stem cell ... successfully demonstrated the,performance of the company,s SmartChip(TM) ... the platform,s ongoing alpha testing program. ...
... - Trial conducted by Novartis to evaluate safety and ... with ribavirin in patients with genotypes 2 and 3 ... Sciences, Inc. (Nasdaq: HGSI ) today announced ... trial that will evaluate the safety and efficacy of ...
Cached Biology Technology:Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 2Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 3Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 4Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay 5WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 2WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 3WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 4WaferGen's SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program 5Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C 2Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C 3Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C 4Human Genome Sciences Announces Initiation of Phase 2b Trial of Albuferon(R) Dosed Monthly in Chronic Hepatitis C 5
(Date:5/24/2013)... and grow by avoiding detection and destruction by the ... to eliminate cancer cells; however, there are many factors ... Regulatory T cells are immune cells that function to ... the Journal of Clinical Investigation , researchers led ... T cells that infiltrate tumors express proteins that can ...
(Date:5/23/2013)... Frontiers in Plant Science , ... gene content and promoter evolution among grasses , ... of stretches of DNA that undergo little change in ... not code for any proteins. Some of these evolutionarily ... to regulate the expression of other genes or the ...
(Date:5/23/2013)... which estrogen suppresses lipid synthesis in the liver, UC ... treating certain liver diseases. , With this finding, ... long-held views in the field. Study results appear in ... Signaling . , "The dogma in the steroid receptor ... located in the nucleus respond to steroid hormones by ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
... WASHINGTON To reduce the risk of another ... oil spill, a new report from the National Academy ... in offshore drilling should take a "system safety" approach ... of operation -- from ensuring the integrity of wells ...
... reporting development of a first-of-its-kind technology that could help ... involving nerve gas and other chemical agents back to ... ingredients for the agent. A report on the technique, ... attacks, appears in ACS, journal Analytical Chemistry . ...
... Athens, Ga. When you cut an apple and ... lemon juice, an antioxidant, and the process slows down. ... the brain as Alzheimer,s disease sets in. The underlying cause ... with the creation of free radicals that cause oxidative stress. ...
Cached Biology News:Industry, regulators should take 'system safety' approach to offshore drilling in aftermath of Deepwater Horizon accident, says new report 2Industry, regulators should take 'system safety' approach to offshore drilling in aftermath of Deepwater Horizon accident, says new report 3Antioxidant has potential in the Alzheimer's fight, UGA researchers find 2
Human GCP-2 is a member of the CXC family of chemokines. It also promotes neutrophil chemotaxis and deganulation. GF063 is an 8.0 kDa protein containing 73 amino acid residues....
... Anti-Matrix Metalloproteinase-2, Hinge Region By immunoblotting the ... protein. It reacts with free MMP-2 or ... buffered aqueous glycerol solution Solution ... 7.4, containing 50% glycerol and 15 mM ...
human Exodus-2 Research Focus: cytokine/growth factor Storage Temperature: -20C Shipping Temperature: 4C...
... exerts its effects by ... receptor, a disulfide-linked heterotetrameric ... Alpha subunits and two ... the following configuration: Beta-Alpha-Alpha-Beta. ...
Biology Products: